Published in AIDS Weekly, September 4th, 1995
"In Belgium, there is no pneumococcal vaccine commercially available," researcher Marc Vanderbruaene and colleagues wrote ("Equal IgG Antibody Response to Pneumococcal Vaccination in All Stages of HIV Disease," Journal of Infectious Diseases, August 1995;172:551-553).
"Because the efficacy of the 23-valent pneumococcal vaccine among persons with HIV remains unproven, this situation will probably not change in the near...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.